Memorial Sloan Kettering Cancer CenterNew York, NY
https://scholar.google.com/citations?user=pM1Bx50AAAAJ&hl=en
Disclosures:
211 - Prognostic Implications of Cerebrospinal Fluid Circulating Tumor DNA (CSF ctDNA) Following Radiation Therapy in Patients with Leptomeningeal Metastasis: Analysis of a Randomized Phase II Trial
Monday, September 30, 202411:15 AM – 11:25 AM ET